Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

PROSTATE CANCER

Synergistic action of combined PARP and ATR inhibition in prostate cancer with ATM loss

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

Original article

  1. Neeb, A. et al. Advanced prostate cancer with ATM loss: PARP and ATR inhibitors. Eur. Urol. https://doi.org/10.1016/j.eururo.2020.10.029 (2020)

    Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Rebecca Tregunna.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tregunna, R. Synergistic action of combined PARP and ATR inhibition in prostate cancer with ATM loss. Nat Rev Urol 18, 4 (2021). https://doi.org/10.1038/s41585-020-00408-2

Download citation

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing